alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company.  The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).

The notices are available for immediate inspection at the Federal Reserve Bank indicated.  The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors.  Comments must be received not later than January 4, 2002.

**A.  Federal Reserve Bank of Boston**                     (Richard Walker, Community Affairs Officer) 600 Atlantic Avenue, Boston, Massachusetts 02106-2204:                

*1.  Santo P. Pasqualucci*, Falmouth, Massachusetts; to acquire voting shares of Falmouth Bancorp, Inc., Falmouth, Massachusetts, and thereby indirectly acquire voting shares of Falmouth Co-operative Bank, Falmouth, Massachusetts.                

**B.  Federal Reserve Bank of Philadelphia**                     (Michael E. Collins, Senior Vice President) 100 North 6th Street, Philadelphia, Pennsylvania  19105-1521:                

*1.  Albert V. Schulze and Michelle A. Schulze*, Orwigsburg, Pennsylvania, Albert V. Schulze (custodian for Alan Jacob Schulze, Rebecca Lauren Schulze, Cameron Prescott Keener, Christian James Keener, and Sara Anne Graver), Michelle Schulze (custodian for Zachary David Garland, Alex Nicholas Pellish, Jillian Michelle Pellish, Brianna Noel Horn, and William I. Horn, III), Dale Keener, Hamburg, Pennsylvania, and Janet Keener, Hamburg, Pennsylvania; to retain shares of Union Bancorp, Inc., Pottsville, Pennsylvania, and thereby indirectly retain voting shares of Union Bank and Trust Company, Pottsville, Pennsylvania.                

Board of Governors of the Federal Reserve System, December 17, 2001.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. 01-31439  Filed 12-20-01; 8:45 am]

BILLING CODE 6210-01-S
## I N T H E C O U R T O F C R I M I N A L A P P E A L S O F T E X A S NO. WR-88,764-03
IN RE AK

EEM ALAJUWON G REEN, Relator
ON AP P LICATION FOR A WRIT OF M ANDAM US CAUSE NO. 1445761 IN THE 177 DISTRICT COURT T H F ROM HARRIS COUNTY
Per curiam . O R D E R Relator has filed a motion for leave to file an application for a writ of mandamus under this Court’s orig inal jurisdiction. He contends, among other things, that he filed an application for a writ of habea s corpus in Har

ris County and his application has not been proper ly forwa rded to this Court. Respondent, the District Clerk of Har ris County , shall forwa

rd Relator’s habea s application to this Court, respond that Relator has not filed a habea s application in Ha rris County , or forward
a copy of an order desig nating issues toge ther with corr espondenc e documenting the date the State
rec eived Relator’s habea s application. See T E X . C O D E C R I M . P R O C . art. 11.07, § 3(c) and (d); T E X . R. A P P . P. 73.4(b)( 5). This motion for leave to file will be held. Respondent shall comply with this order within thirty

day s from the da

te of this order
.2

Filed: 9-9-20 Do not publish
**Exhibit 32.1**

CERTIFICATION PURSUANT TO 

18 U.S.C. SECTION 1350 

AS ADOPTED PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

 

In connection with the Quarterly report of Aura Systems, Inc. (the “Company”) on Form 10-Q (including Amendment No. 1) for the quarterly period ending November 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Melvin Gagerman, Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge:

|   |                                                                                                                  |
|--------|-----------------------------------------------------------------------------------------------------------------------|
| 1.     | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|   |                                                                                                                  |

 

| 2.     | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods indicated. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                           |

 

|               |                                                                                                                        |               |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------|--------------------|
|               |                                                                                                                        |
|               |                                                                                                                        |               |
| Date: May 21, 2009 | By:                                                                                                               | /s/Melvin Gagerman |
|               |  

Melvin GagermanChief Executive Officer, Chief

Financial Officer, Chief Accounting

Officer

 

 

  |
FEDERAL MINE SAFETY AND HEALTH REVIEW COMMISSION 

601 NEW JERSEY AVENUE, NW 

SUITE 9500 

WASHINGTON, DC 20001 

July 1, 2011 

TIME AND DATE: 10:00 a.m., Thursday, July 14, 2011 

PLACE: The Richard V. Backley Hearing Room, 9th Floor, 601 New Jersey 

Avenue, N.W., Washington, D.C. 

STATUS: Open 

MATTERS TO BE 

CONSIDERED: 

The Commission will hear oral argument in the matter Secretary of 

Labor v. Oak Grove Resources, LLC, Docket No. SE 2010-350-R. 

(Issues include whether an order issued by the Secretary of Labor 

was impermissibly duplicative of a previously issued citation.) 

Any person attending this oral argument who requires special 

accessibility features and/or auxiliary aids, such as sign language 

interpreters, must inform the Commission in advance of those 

needs. Subject to 29 C.F.R. § 2706.150(a)(3) and § 2706.160(d). 

CONTACT PERSON 

FOR MORE INFO: Jean Ellen (202) 434-9950 / (202) 708-9300 for TDD Relay / 

1-800-877-8339 for toll free.
EXHIBIT 31.1 

I, Marcel van Heesewijk, certify that:    
1.
I have reviewed this quarterly report on Form 10-QSB of SourcingLink.net, Inc.;    
2.
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;    
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;    
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:     
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;     
b.
[Paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986];     
c.
Evaluate the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and     
d.
Disclosed in this report any changes in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and    
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):     
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 
    
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 
   
Date: October 14, 2004
/s/    Marcel van Heesewijk
<PAGE>

Exhibit 32.2



                            CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the annual report of American Oriental Bioengineering, Inc.
(the "Company") on Form 10-QSB/A for the period ended September 30, 2004 as
filed with the Commission on the date hereof (the "Report"), I, Yanchun Li Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002, that to
the best of my knowledge and belief:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.



By: /s/  Yanchun Li
    ------------------------------------
    YANCHUN LI
    CHIEF FINANCIAL OFFICER

DATED: APRIL 13, 2005
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Balance Sheet at June 30, 1997 (Unaudited) and the Statement of Operations
for the Six Months Ended June 30, 1997 (Unaudited) and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          21,968
<SECURITIES>                                         0
<RECEIVABLES>                                  120,504
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               142,472
<PP&E>                                       4,196,749
<DEPRECIATION>                               2,973,434
<TOTAL-ASSETS>                               1,223,315
<CURRENT-LIABILITIES>                              551
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   1,365,236
<TOTAL-LIABILITY-AND-EQUITY>                 1,365,787
<SALES>                                        336,063
<TOTAL-REVENUES>                               336,959
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                90,427
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                246,532
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            246,532
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   246,532
<EPS-PRIMARY>                                    21.41
<EPS-DILUTED>                                    21.41
        

</TABLE>
FEDERAL MINE SAFETY AND HEALTH REVIEW COMMISSION

SUNSHINE ACT NOTICE

BAC 6735-01

December 30, 2015

TIME AND DATE: 10:00 a.m., Wednesday, January 13, 2016

PLACE: The Richard V. Backley Hearing Room, Room 511N, 1331 

Pennsylvania Avenue, NW, Washington, DC 20004 (enter from F 

Street entrance)

STATUS: Open 

MATTERS TO BE 

CONSIDERED: The Commission will hear oral argument in the matter Secretary of 

Labor v. Hibbing Taconite Company, Docket Nos. LAKE 2013-

231-RM, et al. (Issues include whether the Judge erred in

upholding failure to abate orders.)

Any person attending this oral argument who requires special 

accessibility features and/or auxiliary aids, such as sign language 

interpreters, must inform the Commission in advance of those 

needs. Subject to 29 C.F.R. § 2706.150(a)(3) and § 2706.160(d).

CONTACT PERSON 

FOR MORE INFO: Emogene Johnson (202) 434-9935 / (202) 708-9300 for TDD

Relay / 1-800-877-8339 for toll free.

__________________________________

Sarah L. Stewart

Deputy General Counsel
Unassociated Document


    Exhibit
      10.27

    


    Summary
      of Compensation of the Directors of Generex Biotechnology
      Corporation

    


    It
      is our
      policy to compensate members of our Board of Directors as follows:

    


    
      	
               

            	
              Ÿ

            	
              Directors
                who are not officers or employees of Generex receive cash compensation
                of
                $10,000 each fiscal quarter and are reimbursed for expenses incurred
                in
                connection with attendance at Board and committee meetings.
                

            


    

    


    
      	
               

            	
              Ÿ

            	
              At
                the discretion of the full Board of Directors, directors who are
                not
                officers or employees of Generex may receive stock options to purchase
                shares of our common stock or shares of restricted stock each fiscal
                year.
                The number and terms of such options or shares is within the discretion
                of
                the full Board of Directors.

            


    

    


    
      	
               

            	
              Ÿ

            	
              Directors
                who are officers or employees of Generex do not receive separate
                consideration for their service on the Board of
                Directors.
**Exhibit 31.2**

**CERTIFICATION**

I, Robert S. Chilton certify that:

1.     I havereviewed this Annual Report on Form 10-K of HemaCare Corporation.

2.     Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.     Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, and for,the periods presented in the report:

4.     The registrant’sother certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

(a)    Designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

(b)   Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

(c)    Disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5.     Theregistrant’s other certifying officer(s) and I have disclosed, based onour most recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent functions):

(a)    Allsignificant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

(b)   Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internalcontrol over financial reporting.

Date:   March 20, 2006
| /s/ ROBERT S. CHILTON             |   |
|-----------------------------------|--------|
| Robert S. Chilton                 |   |
| *Chief  Financial Officer*        |   |
| *(Principal  Accounting Officer)* |   |

 

----
|   |                                                                                                                                                               |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1.     | The                Report fully complies with the requirements of section 13(a) or 15(d)                of                the Securities Exchange Act of 1934; and |

| 2. | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company                for the periods indicated. |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                |                                                                                                                                 |                                  |
|-------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|
|                                |                                                                                                                                 |                                  |
| Date:                March __, 2008 | By:                                                                                                                        | /s/ Melvin              Gagerman |
|                                | Melvin                GagermanChief                Executive Officer, ChiefFinancial                Officer, Chief AccountingOfficer |

----
Exhibit 32.0

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HealthExtras, Inc. (the Company) on Form 10-Q for the period
ended June 30, 2007 filed with the Securities and Exchange Commission (the Report), the undersigned hereby certify, pursuant to 18 U.S.C. Section.1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002, that:



|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ---------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered
by the Report.
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|               |  |  |  |  |  |                                     
|-------------- |  |  |  |  |  | ------------------------------------
|               |  |  | 
|August 9, 2007 |  |  |  |  |  | /s/ David T. Blair                  
|               |  |  |  |  |  | David T. Blair                      
|               |  |  |  |  |  | Chief Executive Officer and Director
|               |  |  | 
|               |  |  |  |  |  | /s/ Michael P. Donovan              
|               |  |  |  |  |  | Michael P. Donovan                  
|               |  |  |  |  |  | Chief Financial Officer